References
- Sternberg CN, Scher HI. Advances in the treatment of urothelial tract tumors. Urol Clin North Am 1987; 14: 373–387.
- Ingargiola GB, Lamartina M, Cassata G, et al. Chemioterapia sistemica neoadiuvante con cis-platino e methotrexate nei carcinomi vescicali infiltranti. Acta Urol Ital 1987; 2: 105–109.
- Raghavan D. Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer (review). Br J Urol 1988; 61: 1–8.
- Fossa SD, Splinter T, Roozendaal KJ, et al. A phase II study of 4- epiadriamycin in advanced urothelial transitional cell cancer. Eur J Cancer Clin Oncol 1989; 25: 389–390.
- Lelli G, Tononi A, Casadio M, et al. Cisplatin, epirubicin and methotrexate (PEM) in the treatment of urothelial cancer: a phase II trial. Proc 5th European Conference on Clinical Oncology. London. 3–7 Sept. 1989. abs. P-0565.
- Tonkin K, Tannock I. Evaluation of response and morbidity following treatment of bladder cancer. In Raghavan D: The management of bladder cancer. London: E. Arnold Ltd. 1988: 228–244.
- Stoter G, Splinter TAW, Child JA, et al. Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder. J Urol 1987; 137: 663–667.
- Stoter G. The role of chemotherapy in metastatic and muscle-invasive non-metastatic bladder cancer. Proc 5th European Conference on Clinical Oncology. London. 3–7 Sept. 1989. abs S-32.
- Harker WG, Meyers FJ, Freiha FS, et al. Cisplatin, methotrexate and vinblastine (CMV): an effective chemother apy regimen on metastatic transitional cell carcinoma of the urinary tract: a NCOG study. J Clin Oncol 1985; 3: 1463–1470.
- Sternberg CN, Yagoda A, Scher HI, et al. Preliminary results of M- VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985; 133: 403–407.